Filtered By:
Management: Partnerships
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 1065 results found since Jan 2013.
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research
